Main > A1. CORP. INDEX. In-Iz > Insmed/P C2 > 2008. 04.10.2008. FOB

---

a developer of follow-on biologics and biopharmaceuticals, today announced receipt of a letter and questionnaire from the Chairman and Ranking Member of the U.S. House of Representatives Subcommittee on Health on the possible development of legislation to establish a Follow-On Biologics (FOBs) regulatory pathway.

http://investor.insmed.com/releasedetail.cfm?ReleaseID=304078


2008. 04.10.2008. FOB's products
This section has no products